Robin Cornelissen

机构：Erasmus MC, Erasmus MC Cancer Institute, Erasmus University Rotterdam · ORCID：0000-0002-4289-3092

发表论文 148 篇 · 总被引 8190 次 · h-index 34

代表论文

• Perioperative Nivolumab in Resectable Lung Cancer (2024 · New England Journal of Medicine · 被引 488)
• Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study (2024 · Journal of Clinical Oncology · 被引 211)
• Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study (2024 · Journal of Clinical Oncology · 被引 126)
• Hepatotoxicity in patients with non-small cell lung cancer treated with sotorasib after prior immunotherapy: a comprehensive clinical and pharmacokinetic analysis (2024 · EBioMedicine · 被引 29)
• A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205 (2024 · European Respiratory Journal · 被引 23)
• Perioperative nivolumab (NIVO) vs placebo (PBO) in patients (pts) with resectable NSCLC: Updated survival and biomarker analyses from CheckMate 77T. (2025 · Journal of Clinical Oncology · 被引 22)